Analyst call with Allergan execs stokes anticipation of a plan to split the company in ‘a month or two’
So what’s up at Allergan?
Earlier this week the ubiquitous Evercore ISI analyst Umer Raffat was on the line with company executives to probe into the latest on the numbers as well as CEO Brent Saunders’ recent declaration that he’d be doing something definitive to help long-suffering investors who have watched their shares dwindle in value.
He came away with the impression that a significant company split is on the way. And not on some distant time horizon.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.